May 10 |
Why Axsome Therapeutics Is A Promising Stock Pick In CNS Treatments
|
May 9 |
Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
|
May 8 |
Axsome Therapeutics to Present at Upcoming Investor Conferences
|
May 7 |
Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
|
May 7 |
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript
|
May 7 |
Axsome Therapeutics Inc (AXSM) (Q1 2024) Earnings Call Transcript Highlights: Soaring Revenues ...
|
May 7 |
Q1 2024 Axsome Therapeutics Inc Earnings Call
|
May 6 |
Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript
|
May 6 |
Axsome Therapeutics, Inc. (AXSM) Q1 2024 Earnings Call Transcript
|
May 6 |
Axsome Therapeutics GAAP EPS of -$1.44 misses by $0.21, revenue of $75M beats by $2.15M
|